Rapid and quantitative analysis of unconjugated C27 bile acids in plasma and blood samples by tandem mass spectrometry

A subgroup of peroxisomal disorders, peroxisome biogenesis defects (PBD), can be differentiated by elevated levels of C27 bile acids in plasma and bile. Patients with peroxisomal disorders, who lack the ability to chain-shorten the C27 bile acid intermediates into C24 bile acids, show elevated level...

Full description

Bibliographic Details
Main Authors: D.W. Johnson, H.J. ten Brink, R.C. Schuit, C. Jakobs
Format: Article
Language:English
Published: Elsevier 2001-01-01
Series:Journal of Lipid Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0022227520323300
id doaj-462e85dd967c47adbe0aa9516ca64e3b
record_format Article
spelling doaj-462e85dd967c47adbe0aa9516ca64e3b2021-04-27T04:42:20ZengElsevierJournal of Lipid Research0022-22752001-01-01421916Rapid and quantitative analysis of unconjugated C27 bile acids in plasma and blood samples by tandem mass spectrometryD.W. Johnson0H.J. ten Brink1R.C. Schuit2C. Jakobs3Department of Chemical Pathology, Women's and Children's Hospital, North Adelaide, South Australia 5006, AustraliaDepartment of Clinical Chemistry, Free University Hospital, 1007 MB Amsterdam, The NetherlandsDepartment of Clinical Chemistry, Free University Hospital, 1007 MB Amsterdam, The NetherlandsDepartment of Clinical Chemistry, Free University Hospital, 1007 MB Amsterdam, The NetherlandsA subgroup of peroxisomal disorders, peroxisome biogenesis defects (PBD), can be differentiated by elevated levels of C27 bile acids in plasma and bile. Patients with peroxisomal disorders, who lack the ability to chain-shorten the C27 bile acid intermediates into C24 bile acids, show elevated levels of C27 bile acids, notably 3α,7α-dihydroxy-5β-cholest-26-oic acid and 3α,7α,12α-trihydroxy-5β-cholestan-26-oic acid. C27 bile acids are normally estimated against other bile acid standards, by time-consuming gas chromatography-mass spectrometry and liquid chromatography-tandem mass spectrometry methods, in plasma (minimum of 50 μl). In this article we describe the quantitation of unconjugated di- and trihydroxy C27 bile acids in 5-μl plasma samples and 3-mm blood spots, using deuterium-labeled internal standards. The synthesis of 2H3-labeled di- and trihydroxycoprostanic acids is described. The sample preparation and analysis by electrospray tandem mass spectrometry (ES-MS/MS) takes less than 1 h and features dimethylaminoethyl ester derivatives. The levels of the di- and trihydroxy bile acids are significantly higher in PBD patients than in age-matched control subjects for both plasma and blood spots collected at birth (some stored for up to 18 years). Excellent correlation is observed between the C26:0/C22:0 very long chain fatty acid (VLCFA) ratio and the levels of trihydroxy C27 bile acids in plasma from PBD patients. The ES-MS/MS method can be used to rapidly screen for PBD patients in plasma samples with elevated C26:0/C22:0 VLCFA ratios and in archived collections of neonatal blood spots.—Johnson, D. W., H. J. ten Brink, R. C. Schuit, and C. Jakobs. Rapid and quantitive analysis of unconjugated C27 bile acids in plasma and blood samples by tandem mass spectrometry. J. Lipid Res. 2001. 42: 9–16.http://www.sciencedirect.com/science/article/pii/S0022227520323300peroxisomeES-MS/MSblood spots
collection DOAJ
language English
format Article
sources DOAJ
author D.W. Johnson
H.J. ten Brink
R.C. Schuit
C. Jakobs
spellingShingle D.W. Johnson
H.J. ten Brink
R.C. Schuit
C. Jakobs
Rapid and quantitative analysis of unconjugated C27 bile acids in plasma and blood samples by tandem mass spectrometry
Journal of Lipid Research
peroxisome
ES-MS/MS
blood spots
author_facet D.W. Johnson
H.J. ten Brink
R.C. Schuit
C. Jakobs
author_sort D.W. Johnson
title Rapid and quantitative analysis of unconjugated C27 bile acids in plasma and blood samples by tandem mass spectrometry
title_short Rapid and quantitative analysis of unconjugated C27 bile acids in plasma and blood samples by tandem mass spectrometry
title_full Rapid and quantitative analysis of unconjugated C27 bile acids in plasma and blood samples by tandem mass spectrometry
title_fullStr Rapid and quantitative analysis of unconjugated C27 bile acids in plasma and blood samples by tandem mass spectrometry
title_full_unstemmed Rapid and quantitative analysis of unconjugated C27 bile acids in plasma and blood samples by tandem mass spectrometry
title_sort rapid and quantitative analysis of unconjugated c27 bile acids in plasma and blood samples by tandem mass spectrometry
publisher Elsevier
series Journal of Lipid Research
issn 0022-2275
publishDate 2001-01-01
description A subgroup of peroxisomal disorders, peroxisome biogenesis defects (PBD), can be differentiated by elevated levels of C27 bile acids in plasma and bile. Patients with peroxisomal disorders, who lack the ability to chain-shorten the C27 bile acid intermediates into C24 bile acids, show elevated levels of C27 bile acids, notably 3α,7α-dihydroxy-5β-cholest-26-oic acid and 3α,7α,12α-trihydroxy-5β-cholestan-26-oic acid. C27 bile acids are normally estimated against other bile acid standards, by time-consuming gas chromatography-mass spectrometry and liquid chromatography-tandem mass spectrometry methods, in plasma (minimum of 50 μl). In this article we describe the quantitation of unconjugated di- and trihydroxy C27 bile acids in 5-μl plasma samples and 3-mm blood spots, using deuterium-labeled internal standards. The synthesis of 2H3-labeled di- and trihydroxycoprostanic acids is described. The sample preparation and analysis by electrospray tandem mass spectrometry (ES-MS/MS) takes less than 1 h and features dimethylaminoethyl ester derivatives. The levels of the di- and trihydroxy bile acids are significantly higher in PBD patients than in age-matched control subjects for both plasma and blood spots collected at birth (some stored for up to 18 years). Excellent correlation is observed between the C26:0/C22:0 very long chain fatty acid (VLCFA) ratio and the levels of trihydroxy C27 bile acids in plasma from PBD patients. The ES-MS/MS method can be used to rapidly screen for PBD patients in plasma samples with elevated C26:0/C22:0 VLCFA ratios and in archived collections of neonatal blood spots.—Johnson, D. W., H. J. ten Brink, R. C. Schuit, and C. Jakobs. Rapid and quantitive analysis of unconjugated C27 bile acids in plasma and blood samples by tandem mass spectrometry. J. Lipid Res. 2001. 42: 9–16.
topic peroxisome
ES-MS/MS
blood spots
url http://www.sciencedirect.com/science/article/pii/S0022227520323300
work_keys_str_mv AT dwjohnson rapidandquantitativeanalysisofunconjugatedc27bileacidsinplasmaandbloodsamplesbytandemmassspectrometry
AT hjtenbrink rapidandquantitativeanalysisofunconjugatedc27bileacidsinplasmaandbloodsamplesbytandemmassspectrometry
AT rcschuit rapidandquantitativeanalysisofunconjugatedc27bileacidsinplasmaandbloodsamplesbytandemmassspectrometry
AT cjakobs rapidandquantitativeanalysisofunconjugatedc27bileacidsinplasmaandbloodsamplesbytandemmassspectrometry
_version_ 1721506672342466560